329 related articles for article (PubMed ID: 33633208)
1. Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues.
Parra ER; Zhai J; Tamegnon A; Zhou N; Pandurengan RK; Barreto C; Jiang M; Rice DC; Creasy C; Vaporciyan AA; Hofstetter WL; Tsao AS; Wistuba II; Sepesi B; Haymaker C
Sci Rep; 2021 Feb; 11(1):4530. PubMed ID: 33633208
[TBL] [Abstract][Full Text] [Related]
2. Immuno-profiling and cellular spatial analysis using five immune oncology multiplex immunofluorescence panels for paraffin tumor tissue.
Parra ER; Ferrufino-Schmidt MC; Tamegnon A; Zhang J; Solis L; Jiang M; Ibarguen H; Haymaker C; Lee JJ; Bernatchez C; Wistuba II
Sci Rep; 2021 Apr; 11(1):8511. PubMed ID: 33875760
[TBL] [Abstract][Full Text] [Related]
3. Immune profiling of mouse lung adenocarcinoma paraffin tissues using multiplex immunofluorescence panel: a pilot study.
Zhai J; Tamegnon A; Jiang M; Pandurengan RK; Parra ER
Lab Anim Res; 2024 Jun; 40(1):24. PubMed ID: 38877529
[TBL] [Abstract][Full Text] [Related]
4. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time.
Pasello G; Zago G; Lunardi F; Urso L; Kern I; Vlacic G; Grosso F; Mencoboni M; Ceresoli GL; Schiavon M; Pezzuto F; Pavan A; Vuljan SE; Del Bianco P; Conte P; Rea F; Calabrese F
Ann Oncol; 2018 May; 29(5):1258-1265. PubMed ID: 29514216
[TBL] [Abstract][Full Text] [Related]
5. Validation of multiplex immunofluorescence panels using multispectral microscopy for immune-profiling of formalin-fixed and paraffin-embedded human tumor tissues.
Parra ER; Uraoka N; Jiang M; Cook P; Gibbons D; Forget MA; Bernatchez C; Haymaker C; Wistuba II; Rodriguez-Canales J
Sci Rep; 2017 Oct; 7(1):13380. PubMed ID: 29042640
[TBL] [Abstract][Full Text] [Related]
6. Multiplex immunofluorescence staining and image analysis assay for diffuse large B cell lymphoma.
Lee CW; Ren YJ; Marella M; Wang M; Hartke J; Couto SS
J Immunol Methods; 2020 Mar; 478():112714. PubMed ID: 31783023
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence.
Mori H; Bolen J; Schuetter L; Massion P; Hoyt CC; VandenBerg S; Esserman L; Borowsky AD; Campbell MJ
J Mammary Gland Biol Neoplasia; 2020 Dec; 25(4):417-432. PubMed ID: 33590360
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating lymphocytes are functionally inactivated by CD90+ stromal cells and reactivated by combined Ibrutinib and Rapamycin in human pleural mesothelioma.
Yang H; Berezowska S; Dorn P; Zens P; Chen P; Peng RW; Marti TM; Kocher GJ; Schmid RA; Hall SRR
Theranostics; 2022; 12(1):167-185. PubMed ID: 34987640
[No Abstract] [Full Text] [Related]
9. Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE) Study.
Taube JM; Roman K; Engle EL; Wang C; Ballesteros-Merino C; Jensen SM; McGuire J; Jiang M; Coltharp C; Remeniuk B; Wistuba I; Locke D; Parra ER; Fox BA; Rimm DL; Hoyt C
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34266881
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
Front Immunol; 2020; 11():550250. PubMed ID: 33193316
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic signatures of tumors undergoing T cell attack.
Gokuldass A; Schina A; Lauss M; Harbst K; Chamberlain CA; Draghi A; Westergaard MCW; Nielsen M; Papp K; Sztupinszki Z; Csabai I; Svane IM; Szallasi Z; Jönsson G; Donia M
Cancer Immunol Immunother; 2022 Mar; 71(3):553-563. PubMed ID: 34272988
[TBL] [Abstract][Full Text] [Related]
12. The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma.
Thapa B; Salcedo A; Lin X; Walkiewicz M; Murone C; Ameratunga M; Asadi K; Deb S; Barnett SA; Knight S; Mitchell P; Watkins DN; Boutros PC; John T
J Thorac Oncol; 2017 May; 12(5):850-859. PubMed ID: 28257959
[TBL] [Abstract][Full Text] [Related]
13. High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.
MacGregor HL; Sayad A; Elia A; Wang BX; Katz SR; Shaw PA; Clarke BA; Crome SQ; Robert-Tissot C; Bernardini MQ; Nguyen LT; Ohashi PS
J Immunother Cancer; 2019 Dec; 7(1):357. PubMed ID: 31892360
[TBL] [Abstract][Full Text] [Related]
14. Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function.
Kim HR; Park HJ; Son J; Lee JG; Chung KY; Cho NH; Shim HS; Park S; Kim G; In Yoon H; Kim HG; Jung YW; Cho BC; Park SY; Rha SY; Ha SJ
J Immunother Cancer; 2019 Dec; 7(1):339. PubMed ID: 31801611
[TBL] [Abstract][Full Text] [Related]
15. Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches.
Parra ER; Villalobos P; Behrens C; Jiang M; Pataer A; Swisher SG; William WN; Zhang J; Lee J; Cascone T; Heymach JV; Forget MA; Haymaker C; Bernatchez C; Kalhor N; Weissferdt A; Moran C; Zhang J; Vaporciyan A; Gibbons DL; Sepesi B; Wistuba II
J Immunother Cancer; 2018 Jun; 6(1):48. PubMed ID: 29871672
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the immune microenvironment in malignant pleural mesothelioma reveals prognostic subgroups of patients.
Fusco N; Vaira V; Righi I; Sajjadi E; Venetis K; Lopez G; Cattaneo M; Castellani M; Rosso L; Nosotti M; Clerici M; Ferrero S
Lung Cancer; 2020 Dec; 150():53-61. PubMed ID: 33065463
[TBL] [Abstract][Full Text] [Related]
17. High density and proximity of CD8
Yin Y; Sakakibara R; Honda T; Kirimura S; Daroonpan P; Kobayashi M; Ando K; Ujiie H; Kato T; Kaga K; Mitsumura T; Nakano R; Sakashita H; Matsuge S; Ishibashi H; Akashi T; Hida Y; Morohoshi T; Azuma M; Okubo K; Miyazaki Y
Thorac Cancer; 2023 Jul; 14(20):1991-2000. PubMed ID: 37253418
[TBL] [Abstract][Full Text] [Related]
18. Complex Immune Contextures Characterise Malignant Peritoneal Mesothelioma: Loss of Adaptive Immunological Signature in the More Aggressive Histological Types.
Tazzari M; Brich S; Tuccitto A; Bozzi F; Beretta V; Spagnuolo RD; Negri T; Stacchiotti S; Deraco M; Baratti D; Camisaschi C; Villa A; Vergani B; Rivoltini L; Pilotti S; Castelli C
J Immunol Res; 2018; 2018():5804230. PubMed ID: 30510965
[TBL] [Abstract][Full Text] [Related]
19. High-Throughput Multiplex Immunohistochemical Imaging of the Tumor and Its Microenvironment.
Koh J; Kwak Y; Kim J; Kim WH
Cancer Res Treat; 2020 Jan; 52(1):98-108. PubMed ID: 31163960
[TBL] [Abstract][Full Text] [Related]
20. Spatial modelling of the tumor microenvironment from multiplex immunofluorescence images: methods and applications.
Kumar G; Pandurengan RK; Parra ER; Kannan K; Haymaker C
Front Immunol; 2023; 14():1288802. PubMed ID: 38179056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]